PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462920
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462920
Electroretinogram Market size was valued at USD 604.6 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.
Electroretinography is also utilized to assess the effectiveness of ocular safety protocols. The market demonstrated slight positive growth during and post the COVID-19 pandemic period. A study published on PubMed Central by NCBI indicated that COVID-19 can impact retinal function, including the retinal vasculature. Additionally, a few cases of retinal side effects following COVID-19 vaccination have been reported. Consequently, electroretinograms have been employed for the diagnosis and monitoring of retinal health and associated eye conditions, thereby contributing to market expansion.
Electroretinogram Market- Market Dynamics
Increasing demand for early disease detection, ongoing advancements in technology to propel market demand
The increasing demand for early disease detection, ongoing advancements in technology, and the growing elderly population, which is susceptible to eye ailments like glaucoma and diabetic retinopathy, are anticipated to propel market growth. Given that the eyes are highly sensitive organs, ophthalmic procedures necessitate precision and accuracy, driving market expansion. Furthermore, rising disposable incomes, heightened awareness regarding early disease detection, and increased governmental funding for ophthalmological research and development are bolstering market growth. Retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy, retinitis pigmentosa, and glaucoma are increasingly prevalent due to the aging population and the global rise in diabetes cases. With the growing life expectancy worldwide, a larger proportion of individuals are susceptible to age-related retinal conditions like AMD and glaucoma. Regular monitoring is essential for these conditions, and electroretinography (ERG) plays a vital role in tracking disease progression and response to treatment. The escalating diabetes epidemic has been associated with a concurrent increase in diabetic retinopathy, a diabetes complication that can lead to vision loss. Timely detection through routine ERG testing is crucial for intervention and management. ERG aids in the early identification of various retinal diseases even before significant symptoms appear, which is pivotal for managing disease advancement and devising effective treatments. For example, a research study published by the Lancet Global Health in October 2022 revealed that in India, the estimated national prevalence was 12.5% for diabetic retinopathy and 4.0% for vision-threatening diabetic retinopathy (VTDR), with no significant differences observed between urban and rural areas concerning diabetic retinopathy.
Electroretinogram Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
Based on Instrument Type segmentation, Portable ERG was predicted to show maximum market share in the year 2023
Based on Application segmentation, Clinical Use was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Electroretinogram Market is segmented on the basis of Instrument Type, Product Type, Application, and Region.
The market is divided into two categories based on Instrument Type: fixed ERG machines and portable ERG machines. Portable ERG machines, in comparison to their stationary counterparts, are lighter in weight and offer greater mobility. However, most portable devices are less feature-rich and offer inferior performance compared to fixed models. They are particularly suitable for mobile clinics and hospitals operating in regions with limited infrastructure. For example, the early detection of glaucoma is vital, but it may be challenging due to factors like media opacity or subjective testing inaccuracies. A new test is now available for physicians interested in utilizing electrodiagnostic testing to obtain objective results.
The market is divided into two categories based on Application: Clinical Use and For Research segments. The Clinical Use segment commands the highest market share and exhibits robust growth during the forecast period in the global market. This segment focuses on the significance and potential for substantial application value, market share, and growth assessment in each application area.
Electroretinogram Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
In the domain of electroretinogram (ERG) technology, companies often engage in strategic partnerships to bolster their capabilities, expand market presence, and drive innovation. Collaborations with ophthalmic clinics and research institutions facilitate access to patient populations and clinical expertise for validating and optimizing ERG diagnostic systems. Partnerships with healthcare providers facilitate the integration of ERG testing into routine ophthalmic care, enhancing patient access to diagnostic services and improving disease management. Additionally, alliances with technology firms and software developers spur innovation in ERG instrumentation and data analysis algorithms, leading to improvements in test accuracy, efficiency, and user-friendliness. Moreover, strategic partnerships with regulatory consultants and industry stakeholders aid in navigating regulatory pathways and ensuring compliance with safety and quality standards, thereby facilitating market approval and commercialization. By leveraging synergies through strategic partnerships, companies in the ERG technology market aim to accelerate market adoption, address unmet clinical needs, and enhance patient outcomes in the realm of ophthalmic diagnostics and care.
In April 2021, community physicians gained access to the new Vision Electrophysiology Unit (VEU) at the USC Roski Eye Institute, where ophthalmologists could promptly refer patients for testing. Equipped with cutting-edge technology, the VEU aids in diagnosing inherited retinal illnesses such as retinitis pigmentosa, optic nerve diseases, and various other eye conditions. The VEU boasts advanced equipment, including an electroretinogram (ERG) machine, which evaluates retinal function by capturing the retina's electrical responses to light stimuli.
GLOBAL ELECTRORETINOGRAM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Electro-Diagnostic Imaging, Inc.
Roland Consult Stasche & Finger GmbH
Diagnosys LLC
Konan Medical USA, Inc.
CSO Italia
LKC Technologies, Inc.
Welch Allyn
Diopsys, Inc.
Metrovision
Others